Vaccination

Switzerland approves J&J COVID vaccine

Swiss regulators on Monday gave the green light to Johnson & Johnson's COVID-19 vaccine, after already authorising the jabs made by Pfizer-BioNTech and Moderna.

Diseases, Conditions, Syndromes

Researchers model a safe new normal

Just one year after the World Health Organization declared the novel coronavirus a global pandemic, three COVID-19 vaccines are available in the United States, and more than 2 million Americans are receiving shots each day. ...

Diseases, Conditions, Syndromes

Italy under virus curbs again as Dutch, Irish stop AstraZeneca shots

Coronavirus restrictions were reimposed across much of Italy on Monday, while Ireland and the Netherlands became the latest countries to suspend AstraZeneca's Covid-19 shots over blood clot fears despite the firm and the ...

Vaccination

Supply chain strain threatening COVID vaccine mass scale-up

The unprecedented scaling-up of vaccine manufacturing to counter COVID-19 has sparked dangerous shortages in the supply chain, global players acknowledged Tuesday after brainstorming how to speed up production of the jabs.

Medical economics

COVID-19: Global vaccine promises ring hollow

This week, the first COVID-19 vaccine doses from the United Nations-led COVAX initiative arrived in Africa. This is a long-awaited piece of good news in a climate where vaccine procurement for developing countries has been ...

Neuroscience

Do people with migraine get enough exercise?

More than two-thirds of people with migraine do not get enough exercise, according to a preliminary study released today, February 23, 2021, that will be presented at the American Academy of Neurology's 73rd Annual Meeting ...

page 25 from 40